Title 42The Public Health and WelfareRelease 119-73

§287d–1 National data system and clearinghouse on research on women’s health

Title 42 › Chapter CHAPTER 6A— - PUBLIC HEALTH SERVICE › Subchapter SUBCHAPTER III— - NATIONAL RESEARCH INSTITUTES › Part Part F— - Research on Women’s Health › § 287d–1

Last updated Apr 6, 2026|Official source

Summary

The NIH Director, working with the Director of the Office and the Director of the National Library of Medicine, must create a public data system to collect, store, analyze, find, and share information about women’s health research done or supported by the national research institutes. It must be available to health care providers, researchers, and the public and include a clinical trials registry showing eligibility, sex, age, ethnicity or race, and trial location. Principal investigators must give that information within 30 days after it is available and must report trial results, including any toxicities or adverse effects, when the trial is completed. The NIH Director, with the same partners, must also set up and run a program to provide information on the institutes’ women’s health research and prevention activities.

Full Legal Text

Title 42, §287d–1

The Public Health and Welfare — Source: USLM XML via OLRC

(a)(1)The Director of NIH, in consultation with the Director of the Office and the Director of the National Library of Medicine, shall establish a data system for the collection, storage, analysis, retrieval, and dissemination of information regarding research on women’s health that is conducted or supported by the national research institutes. Information from the data system shall be available through information systems available to health care professionals and providers, researchers, and members of the public.
(2)The data system established under paragraph (1) shall include a registry of clinical trials of experimental treatments that have been developed for research on women’s health. Such registry shall include information on subject eligibility criteria, sex, age, ethnicity or race, and the location of the trial site or sites. Principal investigators of such clinical trials shall provide this information to the registry within 30 days after it is available. Once a trial has been completed, the principal investigator shall provide the registry with information pertaining to the results, including potential toxicities or adverse effects associated with the experimental treatment or treatments evaluated.
(b)The Director of NIH, in consultation with the Director of the Office and with the National Library of Medicine, shall establish, maintain, and operate a program to provide information on research and prevention activities of the national research institutes that relate to research on women’s health.

Reference

Citations & Metadata

Citation

42 U.S.C. § 287d–1

Title 42The Public Health and Welfare

Last Updated

Apr 6, 2026

Release point: 119-73